Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For TXN
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 7.82 4.91 4.55
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 84.42 7.68 4.16
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.29 18.66 18.61
Cash 20.93 11.42 9.44
Capex -8.47 -1.37 -1.26
Free Cash Flow -70.30 -0.25 0.85
Revenue -10.40 4.02 4.49
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -4.03 0.57 0.60
Operating Margin -15.59 0.32 0.38
ROA -25.26 0.03 0.04
ROE -19.81 0.07 0.08
ROIC -34.02 0.03 0.05
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of TXN is permitted for members.
5 Growth
The "Growth Entry" for the Focus of TXN is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of TXN is permitted for members.